GlassScriptPhysician profile
Chirag Shah
NPI 1174550818
$6,731.75
in general payments reported to CMS, 2019-2025
29 companies · $954 in 2025
The $954 reported for 2025 was more than what 76% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $623 · 2020: $576 · 2021: $1,499 · 2022: $977 · 2023: $1,200 · 2024: $903 · 2025: $954.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,837 · Travel and Lodging: $178 · Gift: $36.07 · Education: $5.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,837.13 |
| Travel and Lodging | $178.16 |
| Gift | $36.07 |
| Education | $5.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,002.34 | 2019-2025 | Wavelight Refractive Suite, Wavelight Ex500 Excimer Laser, Clareon |
| Carl Zeiss Meditec, INC. | $1,091.87 | 2020-2025 | Forum, Visumax, Atlas Corneal Topography System |
| Carl Zeiss Meditec USA, INC. | $1,049.06 | 2021-2025 | Visumax |
| Sun Pharmaceutical Industries INC. | $446.01 | 2019-2024 | Cequa |
| Biotissue Holdings INC. | $376.96 | 2019-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $289.79 | 2019-2024 | Tecnis Iol, Tecnis Iol |
| Glaukos Corporation | $242.64 | 2020-2022 | |
| Tarsus Pharmaceuticals, INC. | $173.70 | 2024-2025 | Xdemvy |
| Rxsight INC | $160.23 | 2021-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Eyevance Pharmaceuticals LLC | $148.31 | 2021 | |
| Amgen INC. | $142.23 | 2024 | Tepezza |
| Oyster Point Pharma, INC. | $84.84 | 2022-2023 | Tyrvaya |
| Regeneron Healthcare Solutions, INC. | $74.12 | 2021-2024 | Eylea Hd |
| Eyepoint US, INC. | $71.30 | 2019 | |
| Beaver-Visitec International, INC. | $54.96 | 2021-2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beigene USA, INC. | $52.69 | 2021-2023 | Brukinsa |
| Kala Pharmaceuticals, INC. | $42.53 | 2019-2021 | |
| Cardinal Health 108 LLC | $42.14 | 2025 | |
| Novartis Pharmaceuticals Corporation | $30.48 | 2020-2021 | |
| Apellis Pharmaceuticals, INC. | $18.32 | 2023 | Syfovre |
| Abbvie INC. | $18.27 | 2023 | Durysta |
| Beone Medicines USA, INC. | $17.18 | 2025 | Brukinsa |
| Bausch & Lomb Americas INC. | $15.98 | 2022 | |
| Astellas Pharma US INC | $15.74 | 2023 | |
| Glaxosmithkline, LLC. | $15.39 | 2023 | Trelegy Ellipta |
| Mallinckrodt Hospital Products INC. | $14.52 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $13.48 | 2019 | |
| Shire North American Group INC | $13.41 | 2019 | |
| Allergan, INC. | $13.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chirag Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.